KR19990022524A - 퀴놀리지논형화합물 - Google Patents
퀴놀리지논형화합물 Download PDFInfo
- Publication number
- KR19990022524A KR19990022524A KR1019970709005A KR19970709005A KR19990022524A KR 19990022524 A KR19990022524 A KR 19990022524A KR 1019970709005 A KR1019970709005 A KR 1019970709005A KR 19970709005 A KR19970709005 A KR 19970709005A KR 19990022524 A KR19990022524 A KR 19990022524A
- Authority
- KR
- South Korea
- Prior art keywords
- fluoro
- carboxylic acid
- oxo
- methyl
- quinolizine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/61—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/68—One oxygen atom attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
- C07D455/02—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing not further condensed quinolizine ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US46915995A | 1995-06-06 | 1995-06-06 | |
| US8/469,159 | 1995-06-06 | ||
| US63811296A | 1996-05-29 | 1996-05-29 | |
| US8/638,112 | 1996-05-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR19990022524A true KR19990022524A (ko) | 1999-03-25 |
Family
ID=27042662
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1019970709005A KR19990022524A (ko) | 1995-06-06 | 1996-06-05 | 퀴놀리지논형화합물 |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP0871628A1 (de) |
| JP (1) | JPH11510478A (de) |
| KR (1) | KR19990022524A (de) |
| AU (1) | AU6153096A (de) |
| CA (1) | CA2222322A1 (de) |
| IL (1) | IL122296A0 (de) |
| MX (1) | MX9709416A (de) |
| WO (1) | WO1996039407A1 (de) |
Families Citing this family (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998002151A2 (en) | 1996-07-12 | 1998-01-22 | Leukosite, Inc. | Chemokine receptor antagonists and methods of use therefor |
| US5693813A (en) * | 1997-02-26 | 1997-12-02 | Abbott Laboratories | Process for preparation of 4H-4-oxo-quinolizine-3-carboxylic acid |
| KR100241673B1 (ko) * | 1997-08-09 | 2000-03-02 | 김충섭 | 퀴놀리진 카르복실산 유도체 |
| AU735186B2 (en) | 1997-09-15 | 2001-07-05 | Warner Chilcott Company, Llc | Antimicrobial quinolones, their compositions and uses |
| US6630488B1 (en) | 1998-09-21 | 2003-10-07 | Biochem Pharma, Inc. | Quinolizinones as integrin inhibitors |
| DE69925859T2 (de) | 1998-11-24 | 2006-05-11 | Daiichi Pharmaceutical Co., Ltd. | Cycloalkylsubstituierte aminomethylpyrrolidin-derivate |
| EP2275141A1 (de) | 1999-03-17 | 2011-01-19 | Daiichi Pharmaceutical Co., Ltd. | Geschmacksmaskierte pharmazeutische Zusammensetzungen |
| JP2003516988A (ja) | 1999-12-14 | 2003-05-20 | ニューロサーチ、アクティーゼルスカブ | 新規ヘテロアリール−ジアザビシクロアルカン類 |
| DE19962470A1 (de) * | 1999-12-22 | 2001-07-12 | Schulz Hans Herrmann | Verwendung von Chemotherapeutika |
| SE0100326D0 (sv) * | 2001-02-02 | 2001-02-02 | Astrazeneca Ab | New compounds |
| US7186855B2 (en) | 2001-06-11 | 2007-03-06 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
| US6818787B2 (en) | 2001-06-11 | 2004-11-16 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
| US8048917B2 (en) | 2005-04-06 | 2011-11-01 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
| ATE404558T1 (de) * | 2001-09-28 | 2008-08-15 | Sato Pharma | Antimikrobielle 4-oxochinolizinverbindungen, die als teilstruktur ein 2-pyridonskelett aufweisen |
| US6900224B2 (en) * | 2002-07-31 | 2005-05-31 | The Procter & Gamble Company | Antimicrobial quinolones, their compositions and uses |
| PL1675852T3 (pl) * | 2003-09-22 | 2009-07-31 | Janssen Pharmaceutica Nv | 7-amino-alkilidenylo-heterocykliczne chinolony i naftrydony |
| EP1693364B1 (de) | 2003-12-12 | 2015-05-20 | Daiichi Sankyo Company, Limited | Zwischenprodukte für die herstellung von optisch aktiven cyclopropylaminderivaten und verfahren zur herstellung der zwischenprodukte |
| US7977346B2 (en) | 2006-01-17 | 2011-07-12 | Guoqing Paul Chen | Spiro compounds and methods of use |
| KR101084521B1 (ko) | 2006-03-28 | 2011-11-18 | 워너 칠콧 컴퍼니 엘엘씨 | 퀴놀론 중간체를 제조하기 위한 커플링 방법 |
| MX2008012328A (es) | 2006-03-28 | 2008-10-09 | Procter & Gamble | Sales de malato, y polimorfos de acido (3s,5s)-7-[3-amino-5-metil- piperidinil]-1-ciclopropil-1,4-dihidro-8-metoxi-4-oxo-3-quinolinc arboxilico. |
| MY162052A (en) * | 2007-01-05 | 2017-05-31 | Daiichi Sankyo Co Ltd | Fused substitute aminopyrrolidine derivative |
| CN101622240B (zh) * | 2007-01-05 | 2014-07-23 | 第一三共株式会社 | 稠合取代氨基吡咯烷衍生物 |
| CA2707447C (en) | 2007-12-26 | 2016-03-08 | Banyu Pharmaceutical Co., Ltd. | Sulfonyl-substituted 6-membered ring derivative |
| JP5433992B2 (ja) * | 2008-06-26 | 2014-03-05 | Ｄｉｃ株式会社 | フルオロクロマノール誘導体の製造方法 |
| JP5433996B2 (ja) * | 2008-07-10 | 2014-03-05 | Ｄｉｃ株式会社 | フルオロフェノール誘導体の製造方法 |
| EP2423211B1 (de) * | 2009-04-20 | 2014-04-16 | Kaneka Corporation | Verfahren zur herstellung von (1s,6s)- oder (1r,6r)-cis-2,8-diazabicyclo[4.3.0]nonan und zwischenprodukt |
| US8796297B2 (en) | 2009-06-30 | 2014-08-05 | Abbvie Inc. | 4-substituted-2-amino-pyrimidine derivatives |
| WO2011031745A1 (en) | 2009-09-09 | 2011-03-17 | Achaogen, Inc. | Antibacterial fluoroquinolone analogs |
| JP5487425B2 (ja) * | 2009-09-11 | 2014-05-07 | 毅 野田 | 光学活性２−置換−３−アミノピペリジン誘導体および製造方法 |
| JP5759470B2 (ja) | 2009-10-23 | 2015-08-05 | ヤンセン ファーマシューティカ エヌ．ベー． | オレキシン受容体調節因子としての二置換オクタヒドロピロロ［３，４−ｃ］ピロール |
| EA029542B1 (ru) | 2012-02-10 | 2018-04-30 | ПиТиСи ТЕРАПЬЮТИКС, ИНК. | ПРОИЗВОДНЫЕ 4Н-ПИРИДО[1,2-а]ПИРИМИДИН-4-ОНА ДЛЯ ЛЕЧЕНИЯ СПИНАЛЬНОЙ МЫШЕЧНОЙ АТРОФИИ |
| WO2016196386A1 (en) | 2015-05-30 | 2016-12-08 | Ptc Therapeutics, Inc. | Methods for modulating rna splicing |
| EP3848035A1 (de) | 2015-12-10 | 2021-07-14 | PTC Therapeutics, Inc. | 1,4-disubstituierte pyridazinverbindungen zur behandlung der huntington krankheit |
| KR102559922B1 (ko) | 2016-03-10 | 2023-07-25 | 얀센 파마슈티카 엔.브이. | 오렉신-2 수용체 길항제를 사용한 우울증의 치료 방법 |
| CN106543170B (zh) * | 2016-10-27 | 2018-02-23 | 丹诺医药(苏州）有限公司 | 8‑氯‑1‑环丙基‑7‑氟‑9‑甲基‑4‑氧‑4‑氢‑喹嗪‑3‑羧酸酯及其合成方法 |
| MX2019005588A (es) | 2016-11-28 | 2019-10-15 | Ptc Therapeutics Inc | Metodos para modular corte y empalme de arn. |
| SG11201911615WA (en) | 2017-06-05 | 2020-01-30 | Ptc Therapeutics Inc | Compounds for treating huntington's disease |
| US11608501B2 (en) | 2017-06-14 | 2023-03-21 | Ptc Therapeutics, Inc. | Methods for modifying RNA splicing |
| CA3067591A1 (en) | 2017-06-28 | 2019-01-03 | Ptc Therapeutics, Inc. | Methods for treating huntington's disease |
| CA3067592A1 (en) | 2017-06-28 | 2019-01-03 | Ptc Therapeutics, Inc. | Methods for treating huntington's disease |
| WO2019191092A1 (en) | 2018-03-27 | 2019-10-03 | Ptc Therapeutics, Inc. | Compounds for treating huntington's disease |
| WO2020005882A1 (en) | 2018-06-27 | 2020-01-02 | Ptc Therapeutics, Inc. | Heteroaryl compounds for treating huntington's disease |
| JP7421507B2 (ja) | 2018-06-27 | 2024-01-24 | ピーティーシー セラピューティクス， インコーポレイテッド | ハンチントン病を処置するためのヘテロ環式およびヘテロアリール化合物 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0527889B1 (de) * | 1990-05-02 | 2000-08-02 | Abbott Laboratories | Verbindungen vom chinolizinon-typ |
| AU689809B2 (en) * | 1993-10-14 | 1998-04-09 | Abbott Laboratories | Quinolizinone type compounds |
-
1996
- 1996-06-05 JP JP9501420A patent/JPH11510478A/ja active Pending
- 1996-06-05 KR KR1019970709005A patent/KR19990022524A/ko not_active Application Discontinuation
- 1996-06-05 WO PCT/US1996/008991 patent/WO1996039407A1/en not_active Application Discontinuation
- 1996-06-05 IL IL12229696A patent/IL122296A0/xx unknown
- 1996-06-05 CA CA002222322A patent/CA2222322A1/en not_active Abandoned
- 1996-06-05 EP EP96919103A patent/EP0871628A1/de not_active Withdrawn
- 1996-06-05 AU AU61530/96A patent/AU6153096A/en not_active Abandoned
-
1997
- 1997-12-02 MX MX9709416A patent/MX9709416A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU6153096A (en) | 1996-12-24 |
| IL122296A0 (en) | 1998-04-05 |
| JPH11510478A (ja) | 1999-09-14 |
| EP0871628A1 (de) | 1998-10-21 |
| CA2222322A1 (en) | 1996-12-12 |
| MX9709416A (es) | 1998-07-31 |
| WO1996039407A1 (en) | 1996-12-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR19990022524A (ko) | 퀴놀리지논형화합물 | |
| AU689809B2 (en) | Quinolizinone type compounds | |
| US5580872A (en) | Quinolizinone type compounds | |
| US5726182A (en) | Quinolizinone type compounds | |
| US11702418B2 (en) | SOS1 inhibitors | |
| JP2023109932A (ja) | タウタンパク質標的化ｐｒｏｔａｃ、および関連使用方法 | |
| JP3391796B2 (ja) | 新規化合物、その製法および抗腫瘍剤 | |
| KR930004844B1 (ko) | 아자비시클로 퀴놀론 카르복실산 | |
| KR20180063138A (ko) | 아시네토박터 바우만니이에 대항하는 펩티드 거대고리 | |
| JP2004517860A (ja) | Ｈｉｖインテグラーゼ阻害薬として有用なアザ−およびポリアザ−ナフタレニルカルボキサミド類 | |
| TW201202254A (en) | Macrocyclic compounds as Trk kinase inhibitors | |
| JP2514136B2 (ja) | キノリジノン型化合物 | |
| JPH08511028A (ja) | Ｐ物質拮抗剤としてのベンジルオキシキヌクリジン | |
| KR20130010456A (ko) | 신규의 헤테로사이클릭 아크릴아미드 및 약제로서 이의 용도 | |
| AU2009248786B2 (en) | Tricyclic nitrogen containing compounds and their use as antibacterials | |
| JPH09221424A (ja) | 抗腫瘍剤 | |
| US7176313B2 (en) | Anti acid-fast bacterial agent containing pyridonecarboxylic acids as active ingredient | |
| IE902849A1 (en) | Novel compounds | |
| EP2285375B1 (de) | Spiroazaindol-Verbindungen als HIF propylhydroxylase Hemmer | |
| KR20040077920A (ko) | 이미다조[1,2-ａ]피리딘 유도체 | |
| CA2210007A1 (en) | Quinoline carboxylic acid | |
| HUT61304A (en) | Process for producing azetidinyl-substituted pyridone derivatives and pharmaceutical compositions comprising such compounds | |
| TW202409046A (zh) | 氧雜氮雜環庚三烯衍生物 | |
| WO2022199170A1 (zh) | 四环类衍生物、其制备方法和其医药上的用途 | |
| NZ621436A (en) | Bicyclic heterocycle derivatives for the treatment of pulmonary arterial hypertension |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A201 | Request for examination | ||
| E902 | Notification of reason for refusal | ||
| E601 | Decision to refuse application |